| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 596.670 | 580.498 | 450.279 | 467.721 | 465.925 | 516.405 | 489.268 | 516.130 | 545.123 | 579.160 |
| Total Income - EUR | 596.619 | 586.664 | 450.348 | 467.721 | 468.334 | 516.405 | 504.354 | 504.851 | 545.123 | 579.160 |
| Total Expenses - EUR | 493.724 | 598.134 | 448.920 | 463.238 | 463.209 | 506.864 | 496.835 | 496.683 | 527.552 | 550.639 |
| Gross Profit/Loss - EUR | 102.895 | -11.471 | 1.428 | 4.483 | 5.125 | 9.541 | 7.519 | 8.169 | 17.571 | 28.520 |
| Net Profit/Loss - EUR | 102.895 | -11.471 | 1.428 | -194 | 441 | 6.117 | 3.231 | 3.316 | 12.594 | 23.412 |
| Employees | 13 | 18 | 0 | 12 | 12 | 12 | 13 | 10 | 10 | 9 |
Check the financial reports for the company - Bio Dacic S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 11.782 | 13.557 | 9.565 | 1.898 | 1.359 | 3.269 | 21.757 | 2.472 | 2.381 | 2.284 |
| Current Assets | 184.953 | 159.011 | 97.362 | 108.357 | 104.639 | 121.021 | 112.806 | 136.486 | 139.308 | 165.669 |
| Inventories | 181.694 | 127.639 | 68.057 | 80.321 | 72.863 | 89.800 | 94.027 | 110.488 | 108.246 | 124.361 |
| Receivables | 839 | 9.153 | 22.013 | 24.313 | 28.633 | 29.770 | 17.625 | 15.659 | 23.653 | 32.023 |
| Cash | 2.420 | 22.219 | 7.292 | 3.723 | 3.144 | 1.451 | 1.154 | 10.338 | 7.408 | 9.285 |
| Shareholders Funds | 29.163 | 17.395 | 18.306 | 17.775 | 17.873 | 20.109 | 22.896 | 7.377 | 12.646 | 23.464 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 42 | 0 | 44 | 44 |
| Debts | 167.572 | 155.173 | 89.467 | 92.523 | 88.167 | 104.810 | 112.505 | 132.864 | 129.707 | 144.489 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4729 - 4729" | |||||||||
| CAEN Financial Year |
4729
|
|||||||||
Comments - Bio Dacic S.r.l.